We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new formulation of the medicine ocrelizumab (Ocrevus 920mg solution for injection) to treat relapsing forms of multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS) in adults.
You must tell DVLA if you have multiple sclerosis - download the correct form to let them know
Analysis of a sample of primary care records relating to diagnosed cases of multiple sclerosis in England.
This document contains a synopsis of causation occurring in Multiple Sclerosis.
The purpose of this leaflet is to give an update on progress with the Risk Sharing Scheme for Disease Modifying Therapies (DMTs) in Multiple Sclerosis.
Explains how commissioners and health professionals can use data and analysis for decisions about neurology services and interventions.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).